In 2019, the Fourth International Symposium on Limulus amebocyte lysate science and protection was held in Guangxi. The conference determined that June 20th of each year was the “Internationa...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
The 32nd European Congress of Clinical Microbiology and Infectious Diseases, which will take place for the first time as a hybrid event both online and on-site in Lisbon.
Era Biology will offer fu...
FungiXpert Cryptococcal Antigen Rapid Test Successfully Approved by Health Canada
We are pleased to announce that our Cryptococcal Capsular Polysaccharide Detection K-Set (Lateral Flow Assay) has b...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...